Latest market price
9.82
+0.26+2.73%
OverviewShort InterestFilings
CTNMQT18Contineum Therapeutics, Inc.·NASDAQ
9.82+2.73%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 28, 2026SC 13GBeneficial ownership statement (passive)
Oct 22, 2026SC 13GBeneficial ownership statement (passive)
Sep 14, 20268-KCurrent report
Sep 08, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 03, 20264Statement of changes in beneficial ownership
Jul 30, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20268-KCurrent report
Jul 10, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20268-KCurrent report
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
#1 / 25 of 175
Page
▼
/ 7